Bromido[1-(?6-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II)

Basit Öğe Kaydı
dc.authoridÖzdemir, İsmail/0000-0001-6325-0216
dc.authoridArslan, Hakan/0000-0003-0046-9442
dc.authoridDüşünceli, Serpil Demir/0000-0001-8765-4039
dc.authoridCetinkaya, Bekir/0000-0002-4551-8650
dc.authorwosidÖzdemir, İsmail/ABI-5192-2020
dc.authorwosidArslan, Hakan/B-1081-2008
dc.authorwosidDüşünceli, Serpil Demir/AAA-7160-2021
dc.authorwosidDemir, Serpil/AAI-1740-2019
dc.contributor.authorArslan, Hakan
dc.contributor.authorVanDerveer, Don
dc.contributor.authorOzdemir, Ismail
dc.contributor.authorDemir, Serpil
dc.contributor.authorCetinkaya, Bekir
dc.date.accessioned2024-08-04T20:31:06Z
dc.date.available2024-08-04T20:31:06Z
dc.date.issued2009
dc.departmentİnönü Üniversitesien_US
dc.description.abstractA new ruthenium complex, [RuBrCl(C28H32N2)], has been synthesized and characterized by elemental analysis, H-1 NMR, C-13 NMR, IR-spectroscopy and a single-crystal X-ray diffraction study. The Ru atom in this complex is best described as having a considerably distorted octahedral coordination environment with the arene occupying three coordination sites. Two further coordination sites are occupied by chloride and bromide ligands, while the sixth site is occupied by the carbene. The carbene portion of the ligand is a benzimidazole ring. This ring is connected to the C6H4C(CH3)(3) arene by a CH2 bridge. This leads to a system with very little apparent strain. The two halogen atoms are disordered between Br and Cl. Two partial Cl atoms share the same sites as two partial Br atoms so that the title compound effectively has one Cl and one Br atom. C-H center dot center dot center dot X (X = Cl, Br) hydrogen bonds help to stabilize the crystal structure.en_US
dc.description.sponsorshipScientific and Technological Research Council of Turkey TUBITAK-CNRS [TBAG-U/181 (106 T716)]; Inonu University [BAP. 2008/03]en_US
dc.description.sponsorshipWe thank the Scientific and Technological Research Council of Turkey TUBITAK-CNRS [TBAG-U/181 (106 T716)] and Inonu University Research Fund (BAP. 2008/03 Gudumlu) for financial support.en_US
dc.identifier.doi10.1107/S1600536808042256
dc.identifier.endpageU1021en_US
dc.identifier.issn1600-5368
dc.identifier.pmid21581560en_US
dc.identifier.scopus2-s2.0-58149476904en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpageM97en_US
dc.identifier.urihttps://doi.org/10.1107/S1600536808042256
dc.identifier.urihttps://hdl.handle.net/11616/94730
dc.identifier.volume65en_US
dc.identifier.wosWOS:000262234500079en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofActa Crystallographica Section E-Structure Reports Onlineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectN-Heterocyclic Carbenesen_US
dc.subjectCrystal-Structureen_US
dc.subjectCatalytic-Activityen_US
dc.subjectAlkene Metathesisen_US
dc.subjectComplexesen_US
dc.subjectCycloisomerizationen_US
dc.titleBromido[1-(?6-4-tert-butylbenzyl)-3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]chloridoruthenium(II)en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu